EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS095-32255 
Organism
Homo sapiens 
Tissue/cell
HMEC 
Coordinate
chrX:40034350-40036250 
TF binding sites/motifs
Number: 7             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
ArntlMA0603.1chrX:40036088-40036098GCACGTGACC-6.02
RREB1MA0073.1chrX:40034411-40034431GGGGGTGGGGTGGGGCGGGG-6.18
RREB1MA0073.1chrX:40036206-40036226CCCCACCCCACCCCCTACCT+7.21
RREB1MA0073.1chrX:40036201-40036221CCCCACCCCACCCCACCCCC+7.67
RREB1MA0073.1chrX:40034406-40034426GGGCTGGGGGTGGGGTGGGG-7.6
ZfxMA0146.2chrX:40034513-40034527CAGGCCCCGGCTGG-6.11
ZfxMA0146.2chrX:40035598-40035612CCGGCCTCGGCCTC+6.28
Number of super-enhancer constituents: 28             
IDCoordinateTissue/cell
SE_01309chrX:40032735-40036795Adrenal_Gland
SE_10489chrX:40028005-40037299CD19_Primary
SE_12441chrX:40028224-40037012CD3
SE_13187chrX:40029966-40036585CD34_Primary_RO01480
SE_13805chrX:40028268-40037234CD34_Primary_RO01536
SE_14344chrX:40029761-40037049CD34_Primary_RO01549
SE_15054chrX:40026645-40037112CD4_Memory_Primary_7pool
SE_26729chrX:40030073-40036950Esophagus
SE_31755chrX:40030098-40036960Gastric
SE_32909chrX:40033848-40036162H1
SE_34319chrX:40025113-40037081HCT-116
SE_39958chrX:40029745-40037040K562
SE_41477chrX:40032964-40037003Left_Ventricle
SE_42747chrX:40030207-40037520Lung
SE_49191chrX:40030107-40036942Right_Atrium
SE_52969chrX:40029971-40037549Small_Intestine
SE_54123chrX:40032886-40037231Spleen
SE_55438chrX:40032592-40037070Thymus
SE_56999chrX:40033538-40036784VACO_400
SE_57737chrX:40034438-40036171VACO_503
SE_59437chrX:40011613-40049393Ly3
SE_60054chrX:40006843-40037107Ly4
SE_61279chrX:40005072-40049257HBL1
SE_61737chrX:40005446-40039231Toledo
SE_62904chrX:40005186-40037678Tonsil
SE_65537chrX:40032894-40036865Pancreatic_islets
SE_66639chrX:40032989-40035974Jurkat
SE_68820chrX:40032750-40036863H9
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 2             
ChromosomeStartEnd
chrX4003437740034649
chrX4003469440035505
Enhancer Sequence
TACTCGCGGG CAGCCTGTTC TGACCTATAC TGTCATTTTT TCCATCGGTC GGGATCGGGC 60
TGGGGGTGGG GTGGGGCGGG GGCTCTCCTC CGAGGGGCTC AGCACGGATC GTTGGGTTTT 120
CCCCGGCGAA CTTAACACGG AGGCAAAAGG GGCAGATGGA AACCAGGCCC CGGCTGGCCC 180
CGCGCGCGTA AGCGCGGCAC TCAGCAGCTC GACGCAAAGC CAGGGCTGGA TTTTCGCGGC 240
CCGGGCCCGG CGGCCGCCCA GCGCCCGCGC GATCCTCTCT CCTTCGGGTT GAGCAAACGT 300
GGTCGCCTAA TTCCGCCCGG GAGACAGCAG CTGTGCGGCG AGAGGGGGAG AAAAAATATC 360
GCAACTTTTC CAACAGAAAG TGTGTGCGCA CACGAGAGGT GAAGGCCCAC CCCGATTCTG 420
TGCACGTATC GACACAGCAT CTAATCAGTG TCACTGCCAG GAATACGCTT CCGCGGCGGG 480
CGACACCGCC GCCCTCGCCA ACCTGCAGGA GGGAGGGGGG ATGCAAATGG CGTCTCGCGT 540
CGTCCTAGAC TCCGCGCAGC ACCCGCTACC GCGACTCCAA GCAGACGTTG CAGCAAACTG 600
GGGTGCAGCG TCTGGGGACG CGAACGCGCA GGCGGCCCGA GCGGTCGCAG GGAAGAGGAA 660
CTAGCACCAC TCCCCGCTAC GAGACCGTTC CCCGCCCCCA CCTCCGGAAG AGCCGCCCTT 720
ACTCGACTGG GGTGAGGGGC GGGAAACTTT GCAAGAAGAC TGTTCCGCGC CTTCCCCGCG 780
TGGCACCTCA GAAGAACGTG GGTGGGTTTC CCGTCCGAGG CCAGACCACG CTACCCTACT 840
TTTCCAGGTT TCGGACCTGA ACCTCGTGGA CTACGGGAGG GAGAGTACAT TTCGGGCCAC 900
TGCGGGGGGC GGAGGGACAC CAAAGACAGG CGTCTTCAAG GGTTCTGGCA GATGGCCAAG 960
TTTGTGTCCT TTCCCTCCCA CGCTAGAGTA GCGCACGCCA CTTTGGGGAA GCGTGAGACC 1020
GTTCACCACC GGCCACGAGG CCACCAATGT CTTCCAGGTG GGGCCGATGG TTTGTCTGCA 1080
GCACTCCCTT CCGCCTTGCG GTCCTCGCCT GGCTCCCACA GTCCTGGGGA GCCCCCAGAG 1140
CTAGCCCGCG TCTTCCCTCG CCCGCTCTTC CGGGGGAAAG GGAGGCTGTT TGTGTGGTGT 1200
GTAGCCCCGC TCCGGCTTGC ACCCCCGCGA GCCACCTCGC AGCCCTCCCC GGCCTCGGCC 1260
TCACGGATCC CCTCCCGGAG TAGCCCCGCG GGCCCCCCCG CCATGCGTAA TGGGGCGCCC 1320
CTGGGACGCA GGCGGGGATG GCGGTTCCGG TCGTTCCGGG ATTTGCGTGC AAGAAGAAAA 1380
CAAGGCCGGC GACTACAAGA GCGGCGACTC CATTCTTGGG GTTCAGACGC CCTCGCAGCC 1440
TCCGCGTCGG TTCCGCTCTC GCCCCGGGAG CCCGCTTCCG TGTCCCTGCC CCCGCCCCCC 1500
AACGATTCCT CGTCCGGCCC GTGCCGCACC ACGCGGAGCT CCGCGCGCCC TGGCTCCCAC 1560
ACCGGTCCCT CCATAACTCG CGCTCCTCCC TCGCTCCGGG CTCGGGGAGC CGCTCGCTCC 1620
CAGCGCCCAG AGTCAGCCGG TTCCACCTTC GGCTGCGAGA GCCGCCGCCC CGCGCCACCC 1680
CCGCCCGGCC CGGCCCTTGT CCCAGCCCGG CTCCCCCGCC AGCTGCGCCG CCACCGCCGC 1740
ACGTGACCCG CCCCCGTCGC GGCTTCCGCT GAGCTGCCTG TTCCGGGGCA CAAACAATTT 1800
TTGCTCTGAC GCGGGGTCTC TCGGGGGCCC TGGCGTCCTC TACTCCCTGC TCCCCACCCC 1860
ACCCCACCCC CTACCTTCCG GGTAGGAGAA CTCAAAACAA 1900